1. Bcr‐Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling. Issue 5 (3rd September 2013) Authors: Yang, Jing; Ikezoe, Takayuki; Nishioka, Chie; Udaka, Keiko; Yokoyama, Akihito Journal: International journal of cancer Issue: Volume 134:Issue 5(2014:Mar. 01) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bcr‐Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling. Issue 5 (3rd September 2013) Authors: Yang, Jing; Ikezoe, Takayuki; Nishioka, Chie; Udaka, Keiko; Yokoyama, Akihito Journal: International journal of cancer Issue: Volume 134:Issue 5(2014:Mar. 01) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carboxylated polyamidoamine dendron-bearing lipid-based assemblies for precise control of intracellular fate of cargo and induction of antigen-specific immune responses. (8th March 2021) Authors: Yuba, Eiji; Sugahara, Yoshikatsu; Yoshizaki, Yuta; Shimizu, Takeyuki; Kasai, Michiyuki; Udaka, Keiko; Kono, Kenji Journal: Biomaterials science Issue: Volume 9:Number 8(2021) Page Start: 3076 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CD34+/CD38− acute myelogenous leukemia cells aberrantly express Aurora kinase A. Issue 11 (10th June 2013) Authors: Yang, Jing; Ikezoe, Takayuki; Nishioka, Chie; Nobumoto, Atsuya; Udaka, Keiko; Yokoyama, Akihito Journal: International journal of cancer Issue: Volume 133:Issue 11(2013:Dec. 01) Page Start: 2706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CD34+/CD38− acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells1. Issue 9 (30th October 2012) Authors: Nishioka, Chie; Ikezoe, Takayuki; Furihata, Mutsuo; Yang, Jing; Serada, Satoshi; Naka, Tetsuji; Nobumoto, Atsuya; Kataoka, Sayo; Tsuda, Masayuki; Udaka, Keiko; Yokoyama, Akihito Journal: International journal of cancer Issue: Volume 132:Issue 9(2013:May 01) Page Start: 2006 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CD82 regulates STAT5/IL‐10 and supports survival of acute myelogenous leukemia cells. Issue 1 (27th July 2013) Authors: Nishioka, Chie; Ikezoe, Takayuki; Yang, Jing; Nobumoto, Atsuya; Kataoka, Sayo; Tsuda, Masayuki; Udaka, Keiko; Yokoyama, Akihito Journal: International journal of cancer Issue: Volume 134:Issue 1(2014:Jan. 01) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of a Promiscuous Epitope Peptide Derived From HSP70. Issue 7 (September 2019) Authors: Matsui, Hiroto; Hazama, Shoichi; Tamada, Koji; Udaka, Keiko; Irie, Atsushi; Nishimura, Yasuharu; Miyakawa, Tomoya; Doi, Shun; Nakajima, Masao; Kanekiyo, Shinsuke; Tokumitsu, Yukio; Shindo, Yoshitaro; Tomochika, Shinobu; Yoshida, Shin; Iida, Michihisa; Suzuki, Nobuaki; Takeda, Shigeru; Yamamoto, S... Journal: Journal of immunotherapy Issue: Volume 42:Issue 7(2019:Sep.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. IMT-03 CLINICAL TRIAL FOR NEWLY DIAGNOSED MALIGNANT GLIOMA WITH WT1-W10 VACCINATION. (16th December 2019) Authors: Kawanishi, Yu; Udaka, Keiko; Yawata, Toshio; Nakai, Eiichi; Fukuda, Hitoshi; Fukui, Naoki; Ueba, Tetsuya Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inflammation and immunity in cancer. (2015) Editors: Seya, Tsukasa; Matsumoto, Misako; Udaka, Keiko; Satō, Noriyuki, 1949- Record Type: Book Extent: 1 online resource (xi, 268 pages), illustrations View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma. (27th February 2014) Authors: Karashima, Takashi; Komatsu, Toshihiro; Niimura, Mayumi; Kawada, Chiaki; Kamada, Masayuki; Inoue, Keiji; Udaka, Keiko; Kuroda, Naoto; Shuin, Taro Journal: International journal of urology Issue: Volume 21:Number 7(2014) Page Start: 702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗